Tag: Lilly

  • Lilly to build $6B weight-loss drug factory in Alabama

    Lilly to build $6B weight-loss drug factory in Alabama

    Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Eli Lilly announced plans to invest more than $6 billion to build a manufacturing plant in Huntsville, Alabama, focused on weight loss medications and other pharmaceutical ingredients. The site will manufacture orforglipron, Lilly’s first oral,…

  • Lilly to build $6.5B Houston factory for its first obesity pill

    Lilly to build $6.5B Houston factory for its first obesity pill

    Dive Brief: Eli Lilly said it will build a $6.5 billion factory in Houston focused on manufacturing the company’s first obesity pill and other small molecule medicines. The 236-acre site will produce active pharmaceutical ingredients, among them orforglipron, a small, oral GLP-1 receptor agonist, according to a news release. The molecule agonist is up for…

  • Lilly to build $5B cancer drug facility in Virginia

    Lilly to build $5B cancer drug facility in Virginia

    Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Eli Lilly said it plans to build a $5 billion manufacturing facility outside of Richmond, Virginia, focused on cancer and autoimmune treatments. Located in Goochland County, the site will make ingredients for Lilly’s antibody-drug conjugate…

  • In pictures | Walter Lilly completes major renovation of Lambeth Palace

    In pictures | Walter Lilly completes major renovation of Lambeth Palace

    Lambeth Palace in south London (Image Wright & Wright Architects / Hufton+Crow) Walter Lilly has completed the first significant refurbishment of Lambeth Palace in more than 70 years – a £40m infrastructure and reservicing project aimed at improving accessibility and sustainability across the historic site. The works were carried out while maintaining the operation of…

  • Eli Lilly expands US manufacturing build-out with $50B target

    Eli Lilly expands US manufacturing build-out with $50B target

    Eli Lilly will invest tens of billions more dollars in U.S. drug manufacturing in a significant enlargement of plans the Indianapolis company had already described as historic. Lilly, which makes the popular obesity medicine Zepbound, previously pledged to spend $23 billion on constructing and refurbishing factories in the U.S. to churn out the company’s new…